Skip to main content

Augusto Rojas MartinezCurrent positions and memberships

  • Full time professor at the School of Medicine, Universidad Autónoma de Nuevo León (UANL). Monterrey, Mexico.
  • Leader, Unit of Experimental Therapies, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León (UANL). Monterrey, Mexico (http://cidics.uanl.mx/terapia-genica-y-celular).
  • Member of the Mexican System of Researchers.
  • Member of the Mexican Academy of Science.
  • Member of the Scientific Committee, Latin American School of Human Genetics, Caxias do Sul, Brazil.
  • Coordinator of the Mexican Node of the HVP (http://hvpmexico.uanl.mx/).

Past Positions

  • President, Mexican Association of Human Genetics (AMGH, www.amgh.org.mx) 2009-2010.
  • President, Latin American Network of Human Genetics (RELAGH, www.relagh.org) 2011-2013.

Grades

  • M.D.: Escuela Colombiana de Medicina (Bogotá, Colombia). 1985.
  • Master in Human Genetics: Universidad de Guadalajara (Guadalajara, Mexico). 1991.
  • D. Sc. In Molecular Biology: School of Medicine, UANL (Monterrey, Mexico). 2000.
  • Postdoctoral training: Center for Cell and Gene Therapy, Baylor College of Medicine (Houston, EE.UU.). 1998.

Lines of research

Gene and cell therapy, human genetics in Latin America, and molecular biology of cancer.

Funding grants

  • University: 8
  • National Council of Science and Technology (CONACYT, Mexico): 7.
  • International (CSIC-Spain, UCMexus-US, 7FP-European Commission, NIH-US): 4.

Published articles

  • 56 indexed in JCR (ISI-Thompson Reuthers).
  • 19 not indexed.

Last articles (2014):

  • Ludwig KU, et al. Evaluating eight newly identified susceptibility loci for nonsyndromic cleft lip with or without cleft palate in a mesoamerican population. Birth Defects Res A Clin Mol Teratol 100:43-47. 2014.
  • Sánchez-Domínguez CN, et al. The tumor necrosis factor α (-308A/G) polymorphism is associated with cystic fibrosis in Mexican patients. PLoS One 9:e90945. 2014.
  • Ludwig K, et al. Strong support for association of variants around FOXE1 and orofacial clefting. J Dental Res 93:376-381. 2014.
  • Lapunzina P, et al. Impact of NGS in the medical sciences: Genetic syndromes with an increased risk of developing cancer as an example of the use of new technologies. Genet Mol Biol 37(1 Suppl):241–249. 2014.
  • Rojas-Martínez A, et al. RELAGH - The challenge of having a scientific network in Latin America: An account from the presidents. Genet Mol Biol 37(1 Suppl):305–309. 2014.
  • Penchaszadeh VB, et al. A Tribute to José María (“Chema”) Cantú. Genet Mol Biol 37(1 Suppl):310–314. 2014.
  • Castro-Rojas C, et al. Farmacogenómica del tratamiento de primera línea en el cáncer gástrico: avances en la identificación de los biomarcadores genómicos de respuesta clínica. Invest Clin 55:185-202. 2014
  • Sánchez-Domínguez CN, et al. Low-income status is an important risk factor in north east Mexican patients with cystic fibrosis. Rev Invest Clin 66:129-135 2014.

Granted Patent

  • CRAd driven by the URR promoter from the human papillomavirus and deficient in E1A functions. Mexican Institute for the Industrial Property (IMPI), patent title 287339. June 1st, 2011.